» Authors » Surajit K Ghosh

Surajit K Ghosh

Explore the profile of Surajit K Ghosh including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 65
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Adhikari N, Choudhury A, Shakya A, Ghosh S, Patgiri S, Singh U, et al.
J Biochem Mol Toxicol . 2022 Dec; 37(4):e23290. PMID: 36541419
In the present work, a library of 120 compounds was prepared using various aliphatic and aromatic amines. Finally, 10 compounds were selected through in silico screening carrying 4-aminobenzoyl-l-glutamic acid and...
2.
Ali F, Alom S, Shakya A, Ghosh S, Singh U, Bhat H
Arch Pharm (Weinheim) . 2022 Mar; 355(5):e2100360. PMID: 35244237
Corona Virus Disease-19 (COVID-19) is a pandemic disease mainly caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It had spread from Wuhan, China, in late 2019 and spread over...
3.
Kashyap A, Choudhury A, Saha A, Adhikari N, Ghosh S, Shakya A, et al.
J Biochem Mol Toxicol . 2021 Jul; 35(9):e22860. PMID: 34313355
The present manuscript deals with the development of novel p-aminobenzoic acid (PABA) associated 1,3,5-triazine derivatives as antimalarial agents. The molecules were developed via microwave-assisted synthesis and structures of compounds were...
4.
Singh S, Mandal M, Masih A, Saha A, Ghosh S, Bhat H, et al.
Arch Pharm (Weinheim) . 2021 Mar; 354(6):e2000363. PMID: 33760298
1,3,5-Triazine and its derivatives have been the epicenter of chemotherapeutic molecules due to their effective biological activities, such as antibacterial, fungicidal, antimalarial, anticancer, antiviral, antimicrobial, anti-inflammatory, antiamoebic, and antitubercular activities....
5.
Gogoi P, Shakya A, Ghosh S, Gogoi N, Gahtori P, Singh N, et al.
J Biochem Mol Toxicol . 2020 Dec; 35(3):e22682. PMID: 33332673
Malaria continues to become a major global health problem, particularly in Sub-Saharan Africa, Asia, and Latin America. The widespread emergence of resistance to first-line drugs has further bolstered an urgent...
6.
Dasgupta S, Ghosh S, Ray S, Mazumder B
Curr Drug Deliv . 2013 Nov; 10(6):656-66. PMID: 24274634
Solid lipid nanoparticles (SLN) are very potential formulations for topical delivery of anti-inflammatory and anti-arthritic drugs. The solid state of the lipid particles enable efficient drug encapsulation and controlled drug...
7.
Dasgupta S, Ghosh S, Ray S, Kaurav S, Mazumder B
Curr Drug Deliv . 2013 Nov; 11(1):132-8. PMID: 24266509
The objective of this work was to increase the solubility, in vitro skin permeability of lornoxicam from semisolid topical formulations and also to investigate the in vivo potential of nanoemulsion...
8.
Dasgupta S, Mazumder B, Ghosh S, Kaurav S
Curr Drug Deliv . 2012 Sep; PMID: 22974255
Solid lipid nanoparticles (SLN) are very potential formulations for topical delivery of anti-inflammatory and anti-arthritic drugs. The solid state of the lipid particle enables efficient drug encapsulation and controlled drug...
9.
Gahtori P, Ghosh S, Parida P, Prakash A, Gogoi K, Bhat H, et al.
Exp Parasitol . 2012 Jan; 130(3):292-9. PMID: 22233734
Present communication deals with the docking study of hybrid phenyl thiazolyl-1,3,5-triazine analogues (1a-36d) on three selected different binding site viz., α, β and γ of wild type Pf-DFHR-TS. In admiration...
10.
Gahtori P, Ghosh S
J Enzyme Inhib Med Chem . 2011 Jun; 27(2):281-93. PMID: 21657948
Two novel series of hybrid class 4-chlorophenylthiazole-s-triazine were synthesized via nucleophilic substitution of 2,4,6-trichloro-1,3,5-triazine with distinguished alkenyl/alkyl/aryl/hetero alkyl-aryl amino and mercapto nucleophiles under nitrogen atmosphere. We identified that the spectrums...